Reports
Sale
Global Autotransfusion Devices Market Share, Size, Analysis: By Product Type: Autotransfusion Systems, Consumables, and Accessories; By Application: Cardiovascular Surgeries, Orthopaedic Surgeries, Neurological Surgeries, Organ Transplantation, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Autotransfusion Devices Market Outlook
The global autotransfusion devices market size attained a value of USD 297.26 million in 2023, driven by developing healthcare infrastructure, rapid diagnosis of diseases, rising incidences of haemorrhage, increasing need for safe and sufficient medical procedures, availability of different types of autotransfusion systems and their exceptional benefits. The market is anticipated to grow at a CAGR of 5.0% during the forecast period of 2024-2032 to attain a value of USD 461.14 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Demand for Intraoperative Autotransfusion Systems to Propel the Market Growth of Autotransfusion Devices
Based on product type, the demand for intraoperative transfusion systems is witnessing a healthy growth. The intraoperative autotransfusion systems enable the collection of a patient's own blood during a surgery or an invasive procedure where the blood loss can be anticipated or unpredictable. The washed red blood cells are then transfused back to the patient’s body after the removal of discarded products like platelets and anticoagulants. It decreases net perioperative blood loss, helps maintain postoperative haemoglobin, reduces the risk of blood-borne diseases, reduces patient care costs, eliminates the risk of receiving wrong blood due to human or clerical error, and helps recycle lost blood products. Moreover, the patient's own fresh red blood cells are known to maintain their flexibility in the microcirculation, thereby becoming immediately active in tissue oxygenation. The government initiatives towards developing national frameworks that would maximise patient safety during intraoperative autotransfusion are likely to bolster the autotransfusion devices market growth over the forecast period.
Market Segmentation
Autotransfusion devices refer to equipment that helps in the autotransfusion of blood, including the offering of autologous blood to a patient during surgical or invasive procedures. The autologous blood is collected from a patient during heavy blood loss, and the washed red blood cells are re-infused into the body. The autotransfusion of blood is safe, cost-effective, and reduces the dependency on allogenic blood.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for autotransfusion devices, by product type, is divided into:
- Autotransfusion Systems
- Intraoperative Autotransfusion Systems
- Post-Operative Autotransfusion Systems
- Dual-Mode Autotransfusion Systems
- Consumables and Accessories
Based on application, the market is segmented into:
- Cardiovascular Surgeries
- Orthopaedic Surgeries
- Neurological Surgeries
- Obstetrics and Gynaecology Surgeries
- Others
On the basis of end-use, the market is classified into:
- Hospitals
- Speciality Clinics
- Others
The regional markets for autotransfusion devices can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Surgeries and the Exceptional Benefits of the Devices to Drive the Market Growth of Autotransfusion Devices
The increasing number of surgeries conducted worldwide, owing to the developing healthcare infrastructure and the rapid diagnosis of diseases, leads to the increased demand for blood for performing these procedures, which is driving the autotransfusion devices market growth. The rising incidences of haemorrhage and the increasing need for safe and sufficient blood and blood products to save lives are propelling the demand for these devices. The autotransfusion of blood offers multiple advantages over donated blood, such as it is cost-effective, does not lose its fluidity and function during storage, reduces the risk of infections and complications, eliminates the dependency on blood bank reserves, and reduces morbidity rate. Additionally, it is considered a safe procedure, owing to the advancements in filtration and sterile techniques. The availability of different types of autotransfusion systems, such as in-line, self-filling, and continuous, is aiding the market development. Continuous autotransfusion is faster, requires less staffing involvement, and poses a reduced risk of contamination. The strong presence of autotransfusion device manufacturers and their initiatives to launch sophisticated, effective, and automated devices are expected to augment the market growth over the forecast period.
Key Players in the Global Market for Autotransfusion Devices
The report gives a detailed analysis of the following key players in the global autotransfusion devices market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- LivaNova PLC
- Haemonetics Corporation
- Medtronic plc
- Fresenius SE & Co. KGaA
- Becton, Dickinson, and Company (BD)
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Autotransfusion Devices Market Overview
3.1 Global Autotransfusion Devices Market Historical Value (2017-2023)
3.2 Global Autotransfusion Devices Market Forecast Value (2024-2032)
4 Global Autotransfusion Devices Market Landscape
4.1 Global Autotransfusion Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Autotransfusion Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Autotransfusion Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Autotransfusion Devices Market Segmentation
6.1 Global Autotransfusion Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Autotransfusion System
6.1.2.1 Intraoperative Autotransfusion System
6.1.2.2 Post-Operative Autotransfusion System
6.1.2.3 Dual-Mode Autotransfusion Systems
6.1.3 Consumables and Accessories
6.2 Global Autotransfusion Devices Market by Application
6.2.1 Market Overview
6.2.2 Cardiovascular Surgeries
6.2.3 Orthopaedic Surgeries
6.2.4 Neurological Surgeries
6.2.5 Organ Transplantation
6.2.6 Obstetrics and Gynaecological Surgeries
6.2.7 Others
6.3 Global Autotransfusion Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Others
6.4 Global Autotransfusion Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Autotransfusion Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Autotransfusion Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Autotransfusion Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Autotransfusion Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Autotransfusion Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 LivaNova PLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Haemonetics Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic plc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fresenius SE & Co. KGaA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Becton, Dickinson, and Company (BD)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Redax
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Braile Biomedica
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Gen world Medical Devices
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 SARSTEDT AG & CO. Kg
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Teleflex Incorporated
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Zimmer Biomet Holdings Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Autotransfusion Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global market Autotransfusion Devices attained a value of USD 297.26 million.
The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to reach a value of USD 461.14 million by 2032.
The major market drivers include the developing healthcare infrastructure, rapid diagnosis of diseases, rising incidences of haemorrhage, increasing need for safe and sufficient medical procedures, availability of different types of autotransfusion systems and their exceptional benefits, need to reduce the dependency on blood bank reserves, and government initiatives to maximise patient safety during intraoperative autotransfusion of blood.
The key trends guiding the growth of the market include the rising number of surgeries worldwide, development of efficient and automated autotransfusion devices, and the increasing penetration of market players in emerging nations.
The major regions are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant product types of autotransfusion devices include autotransfusion systems, and consumables and accessories.
The different applications of autotransfusion devices include cardiovascular surgeries, orthopaedic surgeries, neurological surgeries, and obstetrics and gynaecology surgeries, among others.
The major end uses of autotransfusion devices include hospitals, and speciality clinics, among others.
The major players in the market are LivaNova PLC, Haemonetics Corporation, Medtronic plc, Fresenius SE & Co. KGaA, and Becton, Dickinson, and Company (BD), among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER